Bacterial expression and purification of the ovine type II bone morphogenetic protein receptor ectodomain

Protein Expression and Purification

Volumn 52, Issue 1, 2007, Pages 40-49

  Mace, Peter D ^a   Cutfield, John F ^a   Cutfield, Sue M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Bone morphogenetic protein; Ectodomain; Receptor

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2; PRIMER DNA; RECOMBINANT PROTEIN;

ARTICLE; BIOSYNTHESIS; CHROMATOGRAPHY; ESCHERICHIA COLI; FERMENTATION; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN FOLDING; SOLUBILITY;

BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CHROMATOGRAPHY; DNA PRIMERS; ESCHERICHIA COLI; FERMENTATION; GENE EXPRESSION REGULATION, BACTERIAL; PROTEIN FOLDING; RECOMBINANT PROTEINS; SOLUBILITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; OVIS;

EID: 33845958607     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.07.025     Document Type: Article

References (30)

1. Urist M.R. Bone: formation by autoinduction. Science 150 (1965) 893-899
2. ten Dijke P., Korchynskyi O., Valdimarsdottir G., and Goumans M.-J. Controlling cell fate by bone morphogenetic protein receptors. Mol. Cell. Endocrinol. 211 (2003) 105-113
3. Shimasaki S., Moore R.K., Otsuka F., and Erickson G.F. The bone morphogenetic protein system in mammalian reproduction. Endocr. Rev. 25 (2004) 72-101
4. Liu J., Wilson S., and Reh T. BMP receptor 1b is required for axon guidance and cell survival in the developing retina. Dev. Biol. 256 (2003) 34-48
5. Stottmann R.W., Choi M., Mishina Y., Meyers E.N., and Klingensmith J. BMP receptor Ia is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium. Development 131 (2004) 2205-2218
6. Beppu H., Kawabata M., Hamamoto T., Chytil A., Minowa O., Noda T., and Miyazono K. BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev. Biol. 221 (2000) 249-258
7. ten Dijke P., Yamashita H., Ichijo H., Franzen P., Laiho M., Miyazono K., and Heldin C.H. Characterization of type I receptors for transforming growth factor-β and activin. Science 264 (1994) 101-104
8. Rosenzweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., ten Dijke P., Heldin C.H., and Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA 92 (1995) 7632-7636
9. Boesen C.C., Motyka S.A., Patamawenu A., and Sun P.D. Development of a recombinant bacterial expression system for the active form of a human transforming growth factor β type II receptor ligand binding domain. Protein Expr. Purif. 20 (2000) 98-104
10. Kirsch T., Nickel J., and Sebald W. Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2. FEBS Lett. 468 (2000) 215-219
11. Goetschy J.F., Letourneur O., Cerletti N., and Horisberger M.A. The unglycosylated extracellular domain of type-II receptor for transforming growth factor-β. A novel assay for characterizing ligand affinity and specificity. Eur. J. Biochem. 241 (1996) 355-362
12. Greenwald J., Le V., Corrigan A., Fischer W., Komives E., Vale W., and Choe S. Characterization of the extracellular ligand-binding domain of the type II activin receptor. Biochemistry 37 (1998) 16711-16718
13. Allendorph G.P., Vale W.W., and Choe S. Structure of the ternary signaling complex of a TGF-β superfamily member. Proc. Natl. Acad. Sci. USA 103 (2006) 7643-7648
14. Greenwald J., Groppe J., Gray P., Wiater E., Kwiatkowski W., Vale W., and Choe S. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11 (2003) 605-617
15. Clark E.D.B. Refolding of recombinant proteins. Curr. Opin. Biotechnol. 9 2 (1998) 157-163
16. Lilie H., Schwarz E., and Rudolph R. Advances in refolding of proteins produced in E. coli. Curr. Opin. Biotechnol. 9 5 (1998) 497-501
17. Galloway S.M., McNatty K.P., Cambridge L.M., Laitinen M.P., Juengel J.L., Jokiranta T.S., McLaren R.J., Luiro K., Dodds K.G., Montgomery G.W., Beattie A.E., Davis G.H., and Ritvos O. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat. Genet. 25 (2000) 279-283
18. Hanrahan J.P., Gregan S.M., Mulsant P., Mullen M., Davis G.H., Powell R., and Galloway S.M. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and belclare sheep (Ovis aries). Biol. Reprod. 70 (2004) 900-909
19. Moore R.K., Otsuka F., and Shimasaki S. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J. Biol. Chem. 278 (2003) 304-310
20. Vitt U.A., Mazerbourg S., Klein C., and Hsueh A.J. Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol. Reprod. 67 (2002) 473-480
21. McNatty K.P., Juengel J.L., Reader K.L., Lun S., Myllymaa S., Lawrence S.B., Western A., Meerasahib M.F., Mottershead D.G., Groome N.P., Ritvos O., and Laitinen M.P.E. Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function. Reproduction 129 (2005) 473-480
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
23. LaVallie E.R., DiBlasio E.A., Kovacic S., Grant K.L., Schendel P.F., and McCoy J.M. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (NY) 11 (1993) 187-193
24. Holmgren A. Reduction of disulfides by thioredoxin. Exceptional reactivity of insulin and suggested functions of thioredoxin in mechanism of hormone action. J. Biol. Chem. 254 (1979) 9113-9119
25. Hinck A.P., Walker K.P., Martin N.R., Deep S., Hinck C.S., and Freedberg D.I. Sequential resonance assignments of the extracellular ligand binding domain of the human TGF-β type II receptor. J. Biomol. NMR 18 (2000) 369-370
26. Boesen C.C., Motyka S.A., Patamawenu A., and Sun P.D. Crystallization and preliminary crystallographic studies of human TGF-β type II receptor ligand-binding domain. Acta Crystallogr. D Biol. Crystallogr. 58 (2002) 1214-1216
27. Hober S., Forsberg G., Palm G., Hartmanis M., and Nilsson B. Disulfide exchange folding of insulin-like growth factor 1. Biochemistry 31 (1992) 1749-1756
28. Greenwald J., Fischer W.H., Vale W.W., and Choe S. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. Nat. Struct. Biol. 6 (1999) 18-22
29. Hart P.J., Deep S., Taylor A.B., Shu Z., Hinck C.S., and Hinck A.P. Crystal structure of the human TβR2 ectodomain-TGF-β3 complex. Nat. Struct. Biol. 9 3 (2002) 203-208
30. Hatta T., Konishi H., Katoh E., Natsume T., Ueno N., Kobayashi Y., and Yamazaki T. Identification of the ligand-binding site of the BMP type ia receptor for BMP-4. Biopolymers 55 5 (2000) 399-406